INCY
Incyte Corporation
A biopharmaceutical company that develops treatments for blood cancers and other cancers (JAKAFI, ICLUSIG), plus creams for skin conditions like vitiligo and eczema (OPZELURA). Founded in 1991 in Palo Alto, it began as a genomics pioneer selling its LifeSeq gene database to researchers before pivoting to making its own drugs. Its name blends "insight" with "cyt," the Greek root for cell — a nod to its genome-sequencing roots.
CUSIP: 45337C102HealthcareUS4 holders
Total Value
$1.49B
Total Shares
13.10M
Net Share Change
-267.2K
Activity
1 buying2 selling
Investor
Value
Shares
Weight
Change
